Skip to main content

Lex Cowsert, Ruth Nutt, Charles DeLisi

Premium

Automated Cell of Pittsburgh has appointed Lex Cowsert as CSO. Cowsert was previously VP of functional genomics at Vistagen and held a number of scientific management positions at Isis Pharmaceuticals. At Automated Cell, he will head up drug discovery R&D, including work in disease phenotype quantification, molecular biology, cell biology, and bioinformatics.

 

San Diego, Calif.-based Structural Bioinformatics has hired Ruth Nutt as acting head of drug discovery. Nutt, who previously held research positions at Merck and Corvas International, will also join SBI’s scientific advisory board.

 

Charles DeLisi, dean emeritus of Boston University’s College of Engineering and head of the Biomolecular Systems Laboratory at BU’s Center for Advanced Genomic Technology, has joined the scientific advisory board of Bangalore, India-based Strand Genomics.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.